Healthify and Tangelo establish partnership to increase access to fresh produce
Healthify, a company that works with healthcare organizations to integrate social determinants of health (SDoH) into the healthcare ecosystem, and Tangelo, a company that provides food-as-medicine programs, have announced a partnership to increase access to fresh fruits and vegetables for people in need in Ohio and Michigan. About 38% of Americans are food insecure and the lack of access to healthy and fresh nutrients remains a challenge, said Jeremy Cooley, founder and CEO of Tangelo. This partnership with Healthify allows us to advance our mission to improve access to healthy food so people can eat well and live better.
Healthify and Tangelo Establish Partnership to Increase Access to Fresh Produce
Partnership provides families in Ohio and Michigan the ability to place orders for free fresh fruits and vegetables for home delivery
News provided by
Share this article
NEW YORK, May 11, 2021 /PRNewswire/
Healthify, a company that works with healthcare organizations to integrate social determinants of health (SDoH) into the healthcare ecosystem, and
Tangelo, a company that provides food-as-medicine programs, have announced a partnership to increase access to fresh fruits and vegetables for people in need in Ohio and Michigan. About 38% of Americans are food insecure and the lack of access to healthy and fresh nutrients remains a challenge, said Jeremy Cooley, founder and CEO of Tangelo. This partnership with Healthify allows us to advance our mission to improve access to healthy food so people can eat well and live better.
Care Access Research has teamed up with
AstraZeneca to support the Phase III clinical trial for AZD7442, AstraZeneca’s long-acting monoclonal antibody combination for the potential prevention of COVID-19.
Using Care Access’s Mobile Sites On Demand, the two will develop, deploy and manage clinical research sites across the country to assess the safety and efficacy of AZD7442 for post-exposure prophylaxis and preemptive treatment.
“Traditional methods limit who can participate in a clinical trial and how quickly we can complete the clinical trial,” said Ahmad Namvargolian, CEO of Care Access, in a statement. “We are pleased to provide AstraZeneca the innovative capabilities they need to expedite clinical research operations for this important COVID-19 treatment candidate.”